CREDENCE: A silver lining in the dark cloud of diabetic nephropathy

[...]SGLT2 inhibitors have a strong effect in reducing the risk of deteriorating heart failure, which is closely associated with advanced diabetic nephropathy. A recent study of patients with heart failure and a reduced ejection fraction showed that the risk of deteriorating heart failure or death f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of diabetes investigation Jg. 11; H. 3; S. 527 - 529
Hauptverfasser:	Hanai, Ko, Babazono, Tetsuya
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Japan John Wiley & Sons, Inc 01.05.2020 John Wiley and Sons Inc Wiley
Schlagworte:	Antidiabetics Blood pressure Canagliflozin - therapeutic use Cardiovascular disease Clinical trials Commentaries Confidence intervals Congestive heart failure Diabetes Diabetes mellitus Diabetic Nephropathies - diagnosis Diabetic Nephropathies - drug therapy Diabetic Nephropathies - epidemiology Diabetic nephropathy Enzymes Glucose Heart failure Humans Kidney diseases Kidney Failure, Chronic - diagnosis Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - prevention & control Nephropathy Peptides Randomized Controlled Trials as Topic - methods Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
ISSN:	2040-1116, 2040-1124, 2040-1124
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!